Literature DB >> 20190430

Highly spherical and deformable chitosan microspheres for arterial embolization.

Myung Joo Kang1, Jung Min Park, Woo Sik Choi, Jonghwi Lee, Byung Kook Kwak, Jaehwi Lee.   

Abstract

The aim of this study was to fabricate deformable chitosan (CS) microspheres for arterial embolization. CS microspheres containing poly(ethylene glycol) (PEG) were prepared by ionotropic gelation; PEG was then removed from the CS microspheres to produce the highly porous structure to allow deformability. The porosity was controlled by blending ratios of CS/PEG polymers (CS/PEG=from 100/0 to 15/85) and the effect of porosity on microcatheter delivery was examined. The size range of porous microspheres was 500-600 mum with sphericity between 1.012-1.041. Scanning electron microscope observation confirmed that microporous networks were effectively obtained by PEG extraction proportional to the initial amount of PEG. Water retention capacities, indicative of internal porosities of microspheres, increased with increasing initial amounts of blended PEG. CS microspheres with water retention values of greater than 28% exhibited noticeable deformation and smooth passage through the microcatheter tip. Novel deformable microspheres are, therefore, expected to be clinically applicable for arterial embolization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190430     DOI: 10.1248/cpb.58.288

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Development of biodegradable radiopaque microsphere for arterial embolization-a pig study.

Authors:  Yi-Sheng Liu; Xi-Zhang Lin; Hong-Ming Tsai; Hung-Wen Tsai; Guan-Cheng Chen; Syuan-Fong Chen; Jui-Wen Kang; Chen-Miao Chou; Chiung-Yu Chen
Journal:  World J Radiol       Date:  2015-08-28

Review 2.  Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics.

Authors:  Seong-Chul Hong; Seung-Yup Yoo; Hyeongmin Kim; Jaehwi Lee
Journal:  Mar Drugs       Date:  2017-03-01       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.